LSV Asset Management Cuts Stake in Select Medical Holdings Co. (NYSE:SEM)

LSV Asset Management trimmed its holdings in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 69.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 216,600 shares of the health services provider's stock after selling 494,517 shares during the period. LSV Asset Management owned approximately 0.17% of Select Medical worth $4,083,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. LPL Financial LLC raised its stake in Select Medical by 2.0% during the fourth quarter. LPL Financial LLC now owns 31,441 shares of the health services provider's stock valued at $593,000 after buying an additional 619 shares during the last quarter. Bank of Montreal Can raised its position in shares of Select Medical by 4.5% in the 4th quarter. Bank of Montreal Can now owns 20,030 shares of the health services provider's stock worth $378,000 after purchasing an additional 867 shares during the last quarter. Sippican Capital Advisors grew its position in Select Medical by 7.3% during the 4th quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider's stock valued at $252,000 after purchasing an additional 912 shares during the last quarter. State of New Jersey Common Pension Fund D increased its stake in Select Medical by 2.2% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 56,719 shares of the health services provider's stock valued at $1,069,000 after purchasing an additional 1,234 shares in the last quarter. Finally, Smartleaf Asset Management LLC increased its stake in Select Medical by 179.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock valued at $43,000 after purchasing an additional 1,473 shares in the last quarter. 89.48% of the stock is owned by institutional investors.

Select Medical Stock Performance

NYSE:SEM traded up $0.02 on Friday, hitting $16.35. The stock had a trading volume of 520,861 shares, compared to its average volume of 815,009. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.11 billion, a price-to-earnings ratio of 9.91, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38. The business's 50-day simple moving average is $17.32 and its two-hundred day simple moving average is $23.10. Select Medical Holdings Co. has a 52-week low of $14.99 and a 52-week high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The business had revenue of $1.31 billion for the quarter, compared to analysts' expectations of $1.50 billion. As a group, research analysts predict that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd were given a dividend of $0.0625 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.25 annualized dividend and a dividend yield of 1.53%. Select Medical's payout ratio is 15.15%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on SEM shares. Royal Bank of Canada reduced their price target on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research report on Monday, February 24th. UBS Group decreased their price target on Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. Benchmark raised Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective on the stock in a research report on Monday, February 24th. StockNews.com raised Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Finally, Mizuho began coverage on shares of Select Medical in a report on Wednesday. They set an "outperform" rating and a $25.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $26.80.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.